TRIB

Trinity Biotech
TRIB

Overview Fund Activity

48 hedge funds and large institutions have $76M invested in Trinity Biotech in 2017 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 9 increasing their positions, 16 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
48
Holders Change
-4
Holders Change %
-7.69%
% of All Funds
1.09%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.02%
New
6
Increased
9
Reduced
16
Closed
10
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
Russell Investments Group
Russell Investments Group
United Kingdom
$6.03M
2
Morgan Stanley
Morgan Stanley
New York
$2.38M
3
Renaissance Technologies
Renaissance Technologies
New York
$2.03M
4
SM
Senvest Management
New York
$5.12M
5
State Street
State Street
Massachusetts
$731K

Top Sellers

1
PPA
Parametric Portfolio Associates
Washington
$0
2
Boston Partners
Boston Partners
Massachusetts
$5.49M
3
SCM
Stonepine Capital Management
Oregon
$0
4
D.E. Shaw & Co
D.E. Shaw & Co
New York
$356K
5
LAM
Lapides Asset Management
Connecticut
$5.98M
Name Holding Trade Value Shares
Change 		Shares
Change %
PCM
51
Proxima Capital Management
New York
– -$165K -5,875 Closed
OAM
52
Oxford Asset Management
United Kingdom
– -$105K -3,762 Closed
BO
53
BRR OpCo
Ohio
– -$79K -2,827 Closed
MCC
54
Malaga Cove Capital
California
– -$31K -1,140 Closed
AIM
55
Advantage Investment Management
Iowa
– -$2K -60 Closed
FDCDDQ
56
Federation des caisses Desjardins du Quebec
Quebec, Canada
– -$1.4K -50 Closed
1 2
3